Masimo (MASI) Long-Term Deferred Tax (2010 - 2026)
Masimo's (MASI) quarterly Long-Term Deferred Tax came in at $64.7 million in Q2 2026, up 7.3% year-on-year from $60.3 million in Q2 2025, and down 43.35% quarter-over-quarter from $114.2 million in Q1 2026.
Masimo (MASI) Long-Term Deferred Tax (2010 - 2026) Analysis & Trends
Masimo's Long-Term Deferred Tax history runs 17 years deep, the most recent figure standing at $64.7 million for Q2 2026.
- On a quarterly basis, Long-Term Deferred Tax rose 7.3% year-over-year to $64.7 million in Q2 2026; TTM through Apr 2026 was $64.7 million, a 7.3% increase from a year earlier, with the FY2026 full-year figure at $114.2 million, down 3.55% from the prior year.
- Long-Term Deferred Tax fell to $64.7 million in Q2 2026 per MASI's latest filing, from $114.2 million in the prior quarter.
- Across five years, Long-Term Deferred Tax topped out at $119.3 million in Q3 2025 and bottomed at $33.0 million in Q2 2022.
- The 5-year median for Long-Term Deferred Tax is $59.4 million (2024), against an average of $71.1 million.
- Across the five-year window, Long-Term Deferred Tax jumped 149.65% in 2024 and sank 43.7% in 2025, its largest moves.
- Year by year, Long-Term Deferred Tax stood at $102.5 million in 2022, then increased by 4.59% to $107.2 million in 2023, then rose by 10.45% to $118.4 million in 2024, then advanced by 0.76% to $119.3 million in 2025, then plunged by 45.77% to $64.7 million in 2026.
- Per Business Quant, the three latest MASI Long-Term Deferred Tax figures stand at $64.7 million (Q2 2026), $114.2 million (Q1 2026), and $119.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Masimo | 9.39 Bn | 9.27 Bn | 250.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | 64.70 Mn |
| Jan 3, 2026 | 114.20 Mn |
| Sep 27, 2025 | 119.30 Mn |
| Jun 28, 2025 | 59.30 Mn |
| Mar 29, 2025 | 60.30 Mn |
| Dec 28, 2024 | 118.40 Mn |
| Sep 28, 2024 | 59.60 Mn |
| Jun 29, 2024 | 58.80 Mn |
| Mar 30, 2024 | 107.10 Mn |
| Dec 30, 2023 | 107.20 Mn |
| Sep 30, 2023 | 44.70 Mn |
| Jul 1, 2023 | 42.30 Mn |
| Apr 1, 2023 | 42.90 Mn |
| Dec 31, 2022 | 102.50 Mn |
| Oct 1, 2022 | 37.00 Mn |
| Jul 2, 2022 | 55.10 Mn |
| Apr 2, 2022 | 33.03 Mn |
| Jan 1, 2022 | 52.60 Mn |
| Oct 2, 2021 | 39.29 Mn |
| Jul 3, 2021 | 39.31 Mn |